HALO
NASDAQStockHalozyme Therapeutics, Inc.
$63.98-2.52 (-3.78%)
52-Week Range
$47.91
$81.23
Key Stats
Market Cap
7.6B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.02
Volume
1.2M
Avg Volume
1.7M
Performance
1M
-20.06%
3M
+0.17%
6M
-16.73%
YTD
-9.60%
1Y
+4.09%
3Y
+51.33%
5Y
+45.88%
Price Chart
ETF Exposure
HALO is held by 190 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.34% |
| LSAT | LeaderShares AlphaFactor Tactical Focused ETF | 3.28% |
| PBE | Invesco Biotechnology & Genome ETF | 2.76% |
| CSMD | Congress SMID Growth ETF | 2.43% |
| SCAP | Infrastructure Capital Small Cap Income ETF | 2.40% |
| EWMC | Invesco S&P MidCap 400 Equal Weight ETF | 2.39% |
| GRPM | Invesco S&P MidCap 400 GARP ETF | 2.39% |
| RFG | Invesco S&P MidCap 400 Pure Growth ETF | 1.94% |
| BBP | Virtus Biotech ETF | 1.67% |
| FFLS | The Future Fund Long/Short ETF | 1.67% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 1.50% |
| JMID | Janus Henderson Mid Cap Growth Alpha ETF | 1.41% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.39% |
| XBI | State Street SPDR S&P Biotech ETF | 1.32% |
| CANC | Tema Oncology ETF | 1.28% |
| FFND | One Global ETF | 1.20% |
| ILDR | First Trust Innovation Leaders ETF | 1.20% |
| WGRO | WisdomTree U.S. Growth & Momentum Fund | 1.19% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 1.10% |
| XMHQ | Invesco S&P MidCap Quality ETF | 1.08% |
| BUL | Pacer US Cash Cows Growth ETF | 1.05% |
| FSGS | First Trust SMID Growth Strength ETF | 1.01% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 1.00% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.83% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.76% |
| CALF | Pacer US Small Cap Cash Cows ETF | 0.73% |
| NSCS | Nuveen Small Cap Select | 0.71% |
| IBB | iShares Biotechnology ETF | 0.69% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.68% |
| CGMM | Capital Group U.S. Small and Mid Cap ETF | 0.65% |
| WDNA | WisdomTree BioRevolution Fund | 0.64% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.62% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.61% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.58% |
| AGNG | Global X - Aging Population ETF | 0.57% |
| FLOW | Global X - U.S. Cash Flow Kings 100 ETF | 0.56% |
| LNGR | Global X Aging Population ETF | 0.55% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 0.49% |
| CVRT | Calamos Convertible Equity Alternative ETF | 0.47% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.46% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.46% |
| STSB | iShares Factors US Small Blend Style ETF | 0.43% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.42% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.41% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.41% |
| QGRO | American Century U.S. Quality Growth ETF | 0.40% |
| PKW | Invesco BuyBack Achievers ETF | 0.39% |
| WTV | WisdomTree U.S. Value Fund | 0.38% |
| JPME | JPMorgan Diversified Return U.S. Mid Cap Equity ETF | 0.38% |
| MIDE | Xtrackers S&P MidCap 400 Scored & Screened ETF | 0.38% |
Page 1 of 4Next
About HALO ETF Exposure
Halozyme Therapeutics, Inc. (HALO) is held by 190 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.6B, HALO is a widely held institutional stock. The stock currently trades at $63.98. Investors can gain exposure to HALO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HALO, sorted by portfolio weight.